Clarus Therapeutics Holdings Overview

Clarus Therapeutics Holdings Profit Margin

Profitability ratio analysis for CRXT.

Quarterly Profit Margin

-313.93%

↑ 51.84% YoY

As of Jun 2022

Annual Profit Margin (TTM)

-304.70%

↓ 639.21% YoY

Trailing 12 months ending Jun 2022

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin